Mission

Saving Lives. Restoring Health. Giving Hope.

Vision

LifeNet Health is the world's most trusted provider of transplant solutions — from organ recovery and technologically advanced clinical biologics and cellular therapies, to life sciences solutions that support drug discovery and medical innovation — a leader in the field of regenerative medicine, while always honoring the donors, healthcare professionals, and scientists who enable the healing process.

We want to be your preferred supplier of dental allograft.

Values

• Collaboration
• Creativity
• Passion
• Accountability
• Knowledge
• Integrity
• Urgency

Attributes

• Customer Service and Care
• Innovation
• Quality
• Talented and Dedicated Employees

Through our attributes, we strive for excellence and growth in saving lives, restoring health, and giving hope.

The LifeNet Health Dental Advantage¹

At LifeNet Health, we understand the importance of clinical proof and how that may influence your decision to select one dental allograft over another. There are more than 110 published studies using LifeNet Health dental allografts that have been cited more than 2,000 times. We have more data on our mineralized allografts than any competitor and more data on our demineralized Freeze-Dried Bone Allografts (DFDBA) than all competitors combined. We have the proof you require and the safety you demand.

When partnering with an allograft supplier, we believe the decision should be based on the overall value clinicians and patients expect and deserve. At LifeNet Health, we deliver that value by excelling in six critical areas:

• Safety

  Safety is paramount in everything we do. Since 1995, more than 11 million allografts processed using Allowash® technology have been distributed by LifeNet Health with no disease transmission. Our validated processes, quality systems, and technologies ensure patient safety, reducing the probability of infection that could be caused by an allograft implant. From stringent donor screening and review to controlled processing and terminal sterilization, every step of our donation process prioritizes safety.

• Quality

  LifeNet Health’s tissue processing environment is designed to ensure allograft quality and safety. As both a medical device company and a tissue bank, we adhere to the highest standards of quality control, design control processes, and validation procedures. Our grafts consistently perform as expected, validated by internal assessments and recognized by healthcare organizations, industry partners, and regulatory bodies.
  • Extraordinary Design Control Processes • Validated Processes • Quality Control Post-Processing Testing • ISO, AATB, FDA, CLIA accreditations, registrations and certifications

• Innovation

  LifeNet Health is a leader in our industry, bringing clinicians, patients and researchers the most up-to-date solutions. LifeNet Health consistently provides the products, technologies, and services designed to improve safety, clinical effectiveness, ease of use and, ultimately, cost. Since opening its doors in 2012, the Institute of Regenerative Medicine has been a hub of research and development activity, dedicated to meeting clinical and scientific needs now — and in the future.

• Service

  Customer service is available from 7am to 7pm EST, and on-call support is provided 24 hours a day for emergencies. LifeNet Health also offers a flexible return policy, and on-site representatives from Marketing, and Scientific Affairs who can recommend evidence-based, allograft options for the most common bone and soft tissue grafting procedures.

• Clinical Effectiveness

  Our extensive portfolio of dental allografts consistently performs at the highest level because LifeNet Health has invested considerable resources performing multiple clinical studies to ensure patients' outcomes are positive.

• Supply Chain Reliability

  LifeNet Health offers you a partner with bi-coastal production facilities - ensuring a dedicated supply of much-needed allograft products to your dental office.

1. Dental Competitive Comparison Clinical Literature Review, October 2024.